AFMID and colorectal cancer: As shown in Fig 1I and S1F Fig, TrkC-KF-Gal4DBD is unable to transactivate the UAS-GAL4, unlike deleted in colorectal cancer intracellular domain (DCC-IC), as shown previously [17].